Inventor · disambiguated record
Sandra Grau-Richards
Also filed as: GRAU-RICHARDS SANDRA
17 granted patents·11 pending applications·158 citations·filing 2014–2024
93Inventor score
Top patents by PatentIndex Score
28 records- 0197US11306154B2Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimerHOFFMANN LA ROCHE·Filed 2019·Granted Apr 19, 2022·13 cites·56 claims
- 0297US11267903B2Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimerHOFFMANN LA ROCHE·Filed 2019·Granted Mar 8, 2022·17 cites·46 claims
- 0397US10464981B2Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding moleculesHOFFMANN LA ROCHE·Filed 2016·Granted Nov 5, 2019·33 cites·22 claims
- 0496US10392445B2Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding moleculesHOFFMANN LA ROCHE·Filed 2016·Granted Aug 27, 2019·31 cites·39 claims
- 0595US11149083B2Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moietyHOFFMANN—LA ROCHE INC·Filed 2018·Granted Oct 19, 2021·12 cites·25 claims
- 0695US10526413B2Bispecific antibodies specific for OX40HOFFMANN LA ROCHE·Filed 2016·Granted Jan 7, 2020·23 cites·20 claims
- 0790US11214622B2Antibodies specific for DR5 and methods of useROCHE GLYCART AG·Filed 2018·Granted Jan 4, 2022·6 cites·13 claims
- 0890US9926379B2Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5ROCHE GLYCART AG·Filed 2014·Granted Mar 27, 2018·17 cites·28 claims
- 0987US2025101135A1Antigen binding molecules comprising a tnf family ligand trimerHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1080US12441812B2Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding moleculesHOFFMANN LA ROCHE·Filed 2022·Granted Oct 14, 2025·0 cites·28 claims
- 1179US9975958B2Trimeric antigen binding moleculesHOFFMANN LA ROCHE·Filed 2015·Granted May 22, 2018·3 cites·23 claims
- 1275US12202870B2Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereofHOFFMANN LA ROCHE·Filed 2021·Granted Jan 21, 2025·0 cites·40 claims
- 1375US11639394B2Bispecific antigen binding molecule for a costimulatory TNF receptorHOFFMANN LA ROCHE·Filed 2019·Granted May 2, 2023·1 cites·9 claims
- 1474US11453722B2Bispecific antigen binding molecule for a costimulatory TNF receptorHOFFMANN LA ROCHE·Filed 2019·Granted Sep 27, 2022·1 cites·13 claims
- 1573US12227594B2Bispecific 2+1 contorsbodiesHOFFMANN LA ROCHE·Filed 2018·Granted Feb 18, 2025·1 cites·14 claims
- 1670US12240911B2Bispecific antibodies specific for OX40HOFFMANN LA ROCHE·Filed 2019·Granted Mar 4, 2025·0 cites·20 claims
- 1768US2022073646A1Bispecific antibodies with tetravalency for a costimulatory tnf receptorHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1866US2023123178A1Antigen Binding Molecules comprising a TNF family ligand trimer and PD1 binding moietyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1966US2020270321A1Antigen binding molecules comprising a trimeric tnf family ligandHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 2061US2021009656A1C-terminally fused tnf family ligand trimer-containing antigen binding moleculesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2160US2019194291A1C-terminally fused tnf family ligand trimer-containing antigen binding moleculesHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2257US2019211113A1Bispecific antibodies with tetravalency for a costimulatory tnf receptorHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2355US2019185566A1Antigen Binding Molecules comprising a TNF family ligand trimer and PD1 binding moietyHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2451US2017247467A1Bispecific antibodies with tetravalency for a costimulatory tnf receptorHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2548US2019016771A1Trimeric costimulatory tnf family ligand-containing antigen binding moleculesHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2648US2020392237A1Combination therapy with targeted OX40 agonistsHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2742US11536716B2Cell based assay for determining antibody or ligand binding and functionHOFFMANN LA ROCHE·Filed 2016·Granted Dec 27, 2022·0 cites·26 claims
- 2840US11821897B2Assay for determining antibody or ligand binding and functionHOFFMANN LA ROCHE·Filed 2019·Granted Nov 21, 2023·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Sandra Grau-Richards files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →